Skip to content

Transcutaneous auricular vagus nerve stimulation for postoperative fatigue syndrome in patients undergoing hysterectomy: a prospective, single-center, randomized, double-blind, sham-controlled trial protocol

Transcutaneous auricular vagus nerve stimulation for postoperative fatigue syndrome in patients undergoing hysterectomy: a prospective, single-center, randomized, double-blind, sham-controlled trial protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600132134
Enrollment
Unknown
Registered
2026-09-09
Start date
2026-09-15
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Fatigue Syndrome

Interventions

sham-taVNS group:sham-Transcutaneous auricular vagus nerve stimulation

Sponsors

Huzhou Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. age >=18 years; 2. scheduled for elective hysterectomy; 3. American Society of Anesthesiologists (ASA) physical status I–III; 4. preoperative Christensen Fatigue Scale score <=4; 5. no history of local skin disease affecting the left auricular concha; 6. voluntary provision of written informed consent; 7. no participation in any other clinical trial within the past 3 months;

Exclusion criteria

Exclusion criteria: 1.cognitive dysfunction; 2.severe cardiovascular disease (congestive heart failure, myocardial infarction within the past 6 months, grade III hypertension, severe arrhythmias, stroke with sequelae); 3.hepatic/renal insufficiency (Child-Pugh class C / CKD stage G4); 4.active asthma or acute exacerbation of chronic obstructive pulmonary disease; 5.sinus bradycardia (heart rate <50 beats/min); 6.tinnitus or hoarseness; 7.history of recurrent vasovagal syncope; 8.history of vagotomy;

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative fatigue syndrome;

Secondary

MeasureTime frame
postoperative recovery;Adverse Event;pain;Handgrip strength;Hospital Anxiety and Depression Scale;ICFS-10 scale (10 to 50 points) score;Exploratory follow-up indicators;Richards-Campbell Sleep Questionnaire (RCSQ);Markers of systemic inflammation;

Countries

China

Contacts

Public ContactKeyu Fan

Huzhou Center Hospital

215535169@qq.com+86 17398381638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026